Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 94 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $241,000 | -33.4% | 16,720 | -30.1% | 0.09% | -27.6% |
| Q2 2022 | $362,000 | +19.9% | 23,910 | -6.1% | 0.13% | +35.1% |
| Q1 2022 | $302,000 | +2.0% | 25,450 | +39.6% | 0.09% | +22.1% |
| Q4 2021 | $296,000 | -24.7% | 18,230 | +32.5% | 0.08% | -28.0% |
| Q3 2021 | $393,000 | -12.5% | 13,760 | +3.5% | 0.11% | -15.7% |
| Q2 2021 | $449,000 | +20.1% | 13,290 | +7.4% | 0.13% | +10.4% |
| Q1 2021 | $374,000 | -30.0% | 12,380 | +14.8% | 0.12% | -31.5% |
| Q4 2020 | $534,000 | +40.5% | 10,780 | +9.0% | 0.17% | +20.9% |
| Q3 2020 | $380,000 | -5.2% | 9,890 | +6.5% | 0.14% | -12.6% |
| Q2 2020 | $401,000 | – | 9,290 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,194,278 | $108,639,000 | 6.47% |
| Memorial Sloan Kettering Cancer Center | 216,916 | $10,740,000 | 4.55% |
| Burrage Capital Management LLC | 114,962 | $5,692,000 | 4.34% |
| MPM BioImpact LLC | 674,582 | $33,398,000 | 2.88% |
| First Light Asset Management, LLC | 635,652 | $31,471,000 | 2.33% |
| Cormorant Asset Management, LP | 1,661,647 | $82,268,000 | 1.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 219,419 | $10,863,000 | 1.05% |
| ORACLE INVESTMENT MANAGEMENT INC | 126,342 | $6,255,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 131,016 | $6,487,000 | 0.58% |
| Artal Group S.A. | 285,028 | $14,112,000 | 0.30% |